Tailoring Maintenance Therapy to Cluster of Differentiation 5 Positive (CD5+) Regulatory B Cell Recovery in ANCA Vasculitis
Clinical trial NCT03906227 · TERMINATED
Trial details
- NCT number
- NCT03906227
- Sponsor
- University of North Carolina, Chapel Hill
- Status
- TERMINATED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-28
- Primary completion
- 2025-02-27
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.